Our Leaders

Servier’s ambition to improve patient care comes from the top. Our best-in-class executives pave the way for success.

David K. Lee
David K. Lee
Chief Executive Officer
Michael Bolton
Michael Bolton
General Counsel
Adam Camiel
Adam Camiel Headshot
Chief of Staff
Lynne Kelley
Lynne Kelley
Chief Medical Officer
Erik Lemay
Erik Lemay
Global Head of External Manufacturing
Lisa Mahnke
Lisa Mahnke
Global Head of Clinical Sciences for Oncology/Immuno-oncology
Robert Paglia
Robert Paglia
Head of Market Access
Susan Pandya
Susan Pandya MD
Head of Cancer Metabolism Global Development Oncology & Immuno-Oncology
Wendy Poage
Wendy Poage
Head of Patient Advocacy
Arjun Prasad
Arjun Prasad
Head of Sales & Marketing
Deniz Razon
Deniz Razon
Chief Business Officer
Kelly Schlemm
Kelly Schlemm
Head of Communications and Public Affairs
Samantha Small
Sam Small
Head of Corporate Strategy & Operations
Latarsha Stewart
Latarsha Stewart
Head of Compliance
Sammi Tang
Sammi Tang
Global Biometric Head, Oncology
Eli Taube
Eli Taube
Head of the North America Clinical Operations Hub
Donna Vieraitis
Donna Vieraitis
Head of Human Resources
Mark Yunger
Mark Yunger
Head of Information Technology

More from Servier

About Us

Servier Pharmaceuticals is a privately held pharmaceutical company focused on Oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.

Learn More

Governance

Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.

Learn More

History

Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history. 

Learn More